Loading...
At this year's meeting of the American Society of Clinical Oncology (ASCO 2020), held virtually May 29–31, investigators discussed the latest findings in cancer research. Here, Associate Editor David H. Ilson, MD, PhD, reviews the key presentations on new gastrointestinal cancer therapies. All meeting abstracts can be viewed in the ASCO meeting library.
The 2020 ASCO meeting, despite being conducted on a virtual platform, showcased many important and some practicing-changing trials in gastrointestinal malignancies. One practice-changing study, the open-label, randomized, phase III KEYNOTE-177 trial by Andre and colleagues (abstract LBA4), compared first-line therapy with…